Table 2.
Variable | Unadjusted Incidence Rate Ratio | 95% Confidence Interval | P-value |
---|---|---|---|
Age Category | |||
29–56 days | Reference | - | - |
≤28 days | 2.43 | 2.11–2.81 | <0.001 |
Male sex | 0.94 | 0.81–1.09 | 0.397 |
Race | |||
Non-Hispanic White | Reference | - | - |
Non-Hispanic Black | 0.72 | 0.62–0.85 | <0.001 |
Hispanic | 1.65 | 1.11–2.45 | 0.014 |
Other | 0.60 | 0.45–79 | <0.001 |
Presenting during enterovirus season | 0.97 | 0.84–1.13 | 0.695 |
Transported from other institution | 3.18 | 2.69–3.76 | <0.001 |
Birth History | |||
Premature birth | 2.49 | 2.04–3.03 | <0.001 |
Cesarean section delivery | 1.33 | 1.13–1.57 | 0.001 |
History of Present Illness | |||
Apnea | 1.91 | 1.45–2.52 | <0.001 |
Upper Respiratory Symptoms | 1.05 | 0.99–1.12 | 0.091 |
Gastro-intestinal symptoms | 0.55 | 0.47–0.65 | <0.001 |
Physical Examination | |||
Tachypnea | 2.04 | 1.44–2.89 | <0.001 |
Hypoxia | 2.32 | 1.55–3.49 | <0.001 |
Hypotension | 3.64 | 2.58–5.12 | <0.001 |
Lethargy or irritability | 1.02 | 0.84–1.23 | 0.868 |
Seizure | 1.84 | 1.44–2.36 | <0.001 |
Interventions/Studies Obtained | |||
Required vasopressors | 7.02 | 3.49–14.13 | <0.001 |
Required intubation | 7.61 | 5.68–10.22 | <0.001 |
CSF HSV PCR sent | 2.89 | 2.51–3.33 | <0.001 |
Laboratory Results | |||
Serious bacterial infection | 1.65 | 1.26–2.17 | <0.001 |
Hyponatremia | 3.01 | 1.61–5.67 | 0.001 |
Peripheral WBC count ≥15,000 mm3 | 2.31 | 1.91–2.79 | <0.001 |
Thrombocytopenia | 3.11 | 2.09–4.64 | <0.001 |
Low CSF glucose | 2.15 | 1.64–2.81 | <0.001 |
Elevated CSF protein | 1.41 | 1.16–1.71 | <0.001 |
CSF pleocytosis | 2.16 | 1.84–2.53 | <0.001 |
Traumatic lumbar puncture | 1.14 | 0.98–1.32 | 0.082 |
Abbreviations: CSF, cerebrospinal fluid; HSV, herpes simplex virus; PCR, polymerase chain reaction; WBC, white blood cell count